Tumor Microenvironment-Responsive Nanomaterials as Targeted Delivery Carriers for Photodynamic Anticancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Photodynamic therapy (PDT) uses photosensitizers (PS) and light to generate reactive oxygen species (ROS) for tumor treatment.
• Limitations of current PDT include poor photosensitizer hydrophilicity and targeting, hindering clinical application.
• Stimuli-responsive nanomaterials offer advanced drug delivery capabilities.

Purpose of the Study:

• To review tumor microenvironment-responsive nanomaterials (TMRNs) for targeted delivery of photosensitizers in photodynamic therapy.
• To explore the application of TMRNs in enhancing anticancer photodynamic therapy.
• To highlight the potential of TMRNs in overcoming current PDT limitations.

Main Methods:

• Review of recent studies on TMRNs, including pH-, redox-, enzyme-, and hypoxia-responsive nanomaterials.
• Focus on the use of these TMRNs as carriers for photosensitizers in anticancer PDT.
• Analysis of how TMRNs achieve targeted release and improve PS concentration at tumor sites.

Main Results:

• TMRNs demonstrate the ability to achieve targeted release of photosensitizers specifically within tumor tissues.
• These nanomaterials effectively increase photosensitizer concentration in tumors, leading to enhanced therapeutic effects.
• Targeted delivery by TMRNs significantly reduces the systemic side effects associated with conventional PDT.

Conclusions:

• TMRNs represent a promising strategy to improve the efficacy and safety of photodynamic therapy for cancer treatment.
• The development of stimuli-responsive nanomaterials is crucial for advancing targeted drug delivery in oncology.
• Further research into TMRNs will accelerate the clinical translation and broader application of photodynamic anticancer therapy.